INDSWFTLTD.NS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 26, 2026
Report Source: 2026 2nd Quarter Report
Ind Swift Ltd. Stock Analysis INDSWFTLTD.NS
Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm's divisions include Nova Division, Ethical Division, Generic Division, and Ayurveda Division. The Nova Division is a multispecialty division. Its portfolio covers all the therapeutic segments which are available in all the other divisions like respiratory inclusive of ENT, dentistry, anti-infective, cardio-diabetic and orthopedic therapies. The Nova Division Products include Aclovin, Aclovin - SR, Adelive oil and Agipod D/S. The Ethical Division is focused on gynecology, pediatrics, dermatology and GP and its ambit extends to a wide range of medicines. The Generic Division is divided into various therapeutic segments, namely antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial and anti-depressants. The Ayurveda Division's products include Swift Hangover Capsules, Oliade Oil, Swift Tulsi Drops and Majitrich Capsules.
Read More Ind Swift Ltd (INDSWFTLTD.NS) Chart
Key Statistics of Ind Swift Ltd (INDSWFTLTD.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹15.16Volume
645.16KP/E Ratio (TTM)
6.0052 Week Range
Market Cap
850.39MAvg. Volume
645.16KDividend Yield
-Financial Metrics & Statements of Ind Swift Ltd (INDSWFTLTD.NS)
FAQ's for Ind Swift Ltd (INDSWFTLTD.NS)
- According to Musaffa’s Shariah screening methodology, Ind Swift Ltd (INDSWFTLTD.NS) is currently classified as NOT HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.